Considerations for pre-transfusion immunohaematology testing in patients receiving the anti-CD38 monoclonal antibody daratumumab for the treatment of multiple myeloma
Journal article published in 2018 by
H. Quach,
S. Benson,
H. Haysom,
A.-M. Wilkes,
N. Zacher,
M. Cole-Sinclair,
H. Miles Prince,
P. Mollee,
A. Spencer,
P. Joy Ho,
S. J. Harrison,
C. Lee,
B. Augustson,
J. Daly 
